265 related articles for article (PubMed ID: 11408971)
1. Mastering the value chain. An interview with Mark Levin of Millennium Pharmaceuticals. Interview by David Champion.
Levin M
Harv Bus Rev; 2001 Jun; 79(6):108-15, 148. PubMed ID: 11408971
[TBL] [Abstract][Full Text] [Related]
2. Profit pools: a fresh look at strategy.
Gadiesh O; Gilbert JL
Harv Bus Rev; 1998; 76(3):139-47. PubMed ID: 10179649
[TBL] [Abstract][Full Text] [Related]
3. The five competitive forces that shape strategy.
Porter ME
Harv Bus Rev; 2008 Jan; 86(1):78-93, 137. PubMed ID: 18271320
[TBL] [Abstract][Full Text] [Related]
4. The CEO as organizational architect: an interview with Xerox's Paul Allaire. Interview by Robert Howard.
Allaire P
Harv Bus Rev; 1992; 70(5):106-21. PubMed ID: 10121313
[TBL] [Abstract][Full Text] [Related]
5. Building deals on bedrock.
Harding D; Rovit S
Harv Bus Rev; 2004 Sep; 82(9):121-8, 138. PubMed ID: 15449861
[TBL] [Abstract][Full Text] [Related]
6. Driving change: an interview with Ford Motor Company's Jacques Nasser. Interview by Suzy Wetlaufer.
Nasser J
Harv Bus Rev; 1999; 77(2):76-88, 186. PubMed ID: 10387773
[TBL] [Abstract][Full Text] [Related]
7. Leading change from the top line. Interview by Thomas A Stewart and David Champion.
Hassan F
Harv Bus Rev; 2006; 84(7-8):90-7, 188. PubMed ID: 16846192
[TBL] [Abstract][Full Text] [Related]
8. Rebuilding the R&D engine in big pharma.
Garnier JP
Harv Bus Rev; 2008 May; 86(5):68-70, 72-6, 128. PubMed ID: 18543809
[TBL] [Abstract][Full Text] [Related]
9. Competing with giants. Survival strategies for local companies in emerging markets.
Dawar N; Frost T
Harv Bus Rev; 1999; 77(2):119-29, 187. PubMed ID: 10387768
[TBL] [Abstract][Full Text] [Related]
10. A new mandate for human resources.
Ulrich D
Harv Bus Rev; 1998; 76(1):124-34. PubMed ID: 10176915
[TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
12. Reshaping an industry: Lockheed Martin's survival story.
Augustine NR
Harv Bus Rev; 1997; 75(3):83-94. PubMed ID: 10167598
[TBL] [Abstract][Full Text] [Related]
13. Effective executive management in the pharmaceutical industry.
Tran H; Kleiner BH
J Health Care Finance; 2005; 32(1):8-15. PubMed ID: 18972973
[TBL] [Abstract][Full Text] [Related]
14. The anxiety of learning. Interview by Diane L. Coutu.
Schein EH
Harv Bus Rev; 2002 Mar; 80(3):100-6, 134. PubMed ID: 11894378
[TBL] [Abstract][Full Text] [Related]
15. Beyond offshoring: assess your company's global potential.
Farrell D
Harv Bus Rev; 2004 Dec; 82(12):82-90, 148. PubMed ID: 15605568
[TBL] [Abstract][Full Text] [Related]
16. Fast, global, and entrepreneurial: supply chain management, Hong Kong style. An interview with Victor Fung. Interview by Joan Magretta.
Fung V
Harv Bus Rev; 1998; 76(5):102-14, 187. PubMed ID: 10185426
[TBL] [Abstract][Full Text] [Related]
17. Strategy as revolution.
Hamel G
Harv Bus Rev; 1996; 74(4):69-82. PubMed ID: 10158475
[TBL] [Abstract][Full Text] [Related]
18. Predators and prey: a new ecology of competition.
Moore JF
Harv Bus Rev; 1993; 71(3):75-86. PubMed ID: 10126156
[TBL] [Abstract][Full Text] [Related]
19. To succeed in the long-term, focus on the middle-term.
Moore GA
Harv Bus Rev; 2007; 85(7-8):84-90, 192. PubMed ID: 17642127
[TBL] [Abstract][Full Text] [Related]
20. Making strategy: learning by doing.
Christensen CM
Harv Bus Rev; 1997; 75(6):141-6, 148-56. PubMed ID: 10174795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
